FLNA

Filana Therapeutics, Inc. Common Stock
FLNA

1.76 USD
+0.15
9.32%
At close Updated Apr 16, 4:00 PM EDT
Pre-market
After hours
1.75
-0.01
0.57%
1 day
9.32%
5 days
2.33%
1 month
-9.74%
3 months
-13.73%
6 months
-61.06%
Year to date
-15.79%
1 year
25.71%
5 years
-94.95%
10 years
-89.12%
 

About: Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Employees: 20

Healthcare Biotechnology
0
Funds holding %
of 8,116 funds
Explore Fund Trends
–
Analysts bullish %
See Analyst Outlook
–
Positive news %
Check Journalist POV
Price charts implemented using Lightweight Charts™